U.S. Point-of-Care Molecular Diagnostics Market Projected To Raise At USD 3.92 Billion By 2030
San Francisco, 24 December 2024: The Report U.S. Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report Test Location, By Application (Infectious Diseases, Oncology, Prenatal Testing), By Technology (PCR, Sequencing), By End-use, And Segment Forecasts, 2024 - 2030 The U.S. point-of-care molecular diagnostics market size to reach USD 3.92 billion in 2030 and is projected to grow at a compound annual growth rate (CAGR) of 1.7% from 2024 to 2030. The growth of the market is driven by rise in end-user awareness, along with the increased efficiency of the testing methods and favorability for non-laboratory testing. For instance, in the U.S., approximately 1% infants are diagnosed with congenital heart diseases (CHDs) every year. However, advancements in prenatal testing have led to rapid detection of genetic biomarkers in embryos, thus leading to early diagnosis of CHDs and other genetic disorders. The U.S. point-of-care ...